The effects of this increase in the levels of endothelin-1 in combination with elevated insulin resistance and decreased glucose uptake depend on the target tissue because the expression and activation of endothelin receptor subtypes are tissue-specific. The gene discussed is EDN1; the disease is Insulin resistance.